Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma

NCT00598104 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Due to the lack of enrolment and complexity of design, this study in asthma was terminated. No subjects have been dosed for this study.

Conditions

Interventions

Sponsor

Novartis